Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents
262,90 €
Envío en 4/5 dias
Información del producto
| ISBN | 9781461288886 |
|---|---|
| Editorial | Springer-Verlag New York Inc. |
| Precio (sin IVA) | 248,02 € |
| Impuestos | 14,88 € |
| Precio (IVA incluido) | 262,90 € |
| Disponibilidad | 1 Unidad En almacén externo |
Descripción del producto
The Ninth Annual symposium on New Drugs addressed the problem of determining the risk versus benefit for use of three important classes of cardiovascular agents: thrombolytic, antiarrhythmic, and hypolipidemic agents.